
Ken Fujioka MD
Board of Directors, American Board of Obesity Medicine; President-Elect, National Board of Physician Nutrition Specialists; Founding Director, Center for Weight Management, and Director, Nutrition and Metabolic Research Center, Scripps Clinic, Department of Diabetes and Endocrine, San Diego, CaliforniaDr. Fujioka is currently director of Nutrition and Metabolic research and Obesity Telemedicine at Scripps Clinic in the Department of Diabetes and Endocrine. Dr. Fujioka is proud to say that he is certified in Obesity medicine by ABOM and currently President-elect of the National board of physician nutrition specialist.
Dr. Fujioka has authored over 100 papers in Peer reviewed journals on weight management and related comorbid disease. He has participated as a PI on over 100 clinical trials and sub PI on numerous NIH grants.
He has authored a comprehensive standard of care for the California State Medical board (1997) on obesity treatment and lectured to numerous political groups (Sacramento, Washington DC, etc) on obesity treatments.
He currently spends half his time doing research and half his time seeing patients.
Disclosures
Dr. Fujioka reports the following, as of January 2020:
The following pharmaceutical companies are companies that I have done business with over the past 12-24 months. Below I have outlined my relationship with these companies. These companies have a diet, metabolic or weight loss agent, or device that I have researched or have been asked to consult about. I do not sit on any of the financial boards of these companies. I also do not own individual stocks of any of these companies. I am not employed as an employee by any of these companies. Consulting is usually done on a scientific advisory board. Research grants go directly to Scripps Clinic and Scripps Health.
Company |
Research Grant |
Consulting Agreement |
Speakers Bureau |
|
|
|
|
Novonordisk |
no |
Yes |
Yes |
Gelesis |
No |
Yes |
no |
KVK-tech |
No |
Yes |
no |
Amgen |
No |
Yes |
no |
Sunovion |
No |
Yes |
no |
Phenomix |
No |
Yes |
no |
Boehringer Ingelheim |
No |
Yes |
no |
Janssen Global Services |
No |
Yes |
no |
Roivant |
No |
Yes |
no |
Takeda |
No |
Yes |
yes |
Addtionally, Dr. Fujioka has no agreements with the company that has Setmelanotide or Rhythm pharma.